This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: Inventor Hans Bikel: A Legacy of Innovation in Pharmaceuticals
Introduction: Hans Bikel, located in Binningen, Switzerland, is known for his contributions to the field of pharmaceuticals. With a sole patent to his name, he has made a significant impact in drug development and chemical research.
Latest Patents: Bikel's most notable patent is for "6-Acylamino-penam-3-carboxylic acids and 7-acylamino-3-cephem-4-carboxylic acids." This complex compound features an acyl group with specific chemical properties, where R1 is hydrogen, R2 is an optionally substituted phenyl, thienyl, or furyl, or where R1 and R2 together form an optionally substituted cycloalkyl. R, in turn, is a radical that can connect through a carbon, oxygen, sulfur, or nitrogen atom.
Career Highlights: Hans Bikel is affiliated with Ciba-Geigy Corporation, which has a long-standing reputation in the pharmaceutical industry. His work has contributed to advancements in antibiotic development and other medicinal compounds, showcasing his expertise in organic chemistry.
Collaborations: Throughout his career, Bikel has collaborated with esteemed colleagues such as Bruno Fechtig and Karoly Kocsis. These partnerships highlight the collaborative spirit in the field of innovation and research, as they work together to push the boundaries of pharmaceutical science.
Conclusion: Hans Bikel’s contributions to pharmaceuticals through his patent signify the importance of innovation in addressing health challenges. His career reflects a dedication to advancing medical knowledge and improving drug efficacy, cementing his status as a noteworthy inventor in the industry.